Missouri 2026 Regular Session Status: In Committee

SB 1200 — Removes the expiration date on certain provisions relating to gender transition

Last action — Second Read and Referred S Families, Seniors and Health Committee

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed Senate
  4. 4
    Passed House
  5. 5
    To Executive
  6. 6
    Enacted

This bill is in committee in the Senate. Introduced December 01, 2025. It must pass committee before a floor vote.

Next likely step: a committee vote, then a floor vote in the Senate.

Odds of enactment

Low chance

Based on the sponsor, cosponsors, and committee posture, this bill has a low chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Stalled 14% · moderate confidence

  • In Committee

    Current position in the legislative process.

  • 1 sponsor

    1 primary, 0 co-sponsors signed on.

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

Summary

SB 1200 - Currently, a health care provider shall not knowingly prescribe or administer cross-sex hormones or puberty-blocking drugs for the purpose of a gender transition for children. This provision of law does not apply to those children who were prescribed or administered such drugs prior to August 28, 2023. This prohibition on the prescription of cross-sex hormones or puberty-blocking drugs to children shall expire on August 28, 2027. This act removes that expiration date. Additionally, the provision excluding those children already prescribed or administered the hormones or drugs prior to August 28, 2023, from the general prohibition on the prescription of cross-sex hormones or puberty-blocking drugs to children shall expire on March 1, 2027. This act is substantially similar to HCS/HBs 2033, 1608, 1672, & 1854 (2026), SB 1264 (2026), SB 861 (2026), SB 75 (2025), HCS#2/SS#2/SCS/SB 10 (2025), SB 26 (2025), SB 249 (2025), SB 493 (2025), SB 1185 (2024), SB 726 (2024), and SB 776 (2024). SARAH HASKINS

Bill Text

Action History

  1. Second Read and Referred S Families, Seniors and Health Committee

  2. S First Read

  3. Prefiled

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 0 co-sponsors · 198 not signed on

Sponsors (1)

Co-sponsors (0)

None.

Not signed on (198)

198 members have not signed on to this bill.

Show all 198 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

civil-rights healthcare
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does SB 1200 do?
SB 1200 - Currently, a health care provider shall not knowingly prescribe or administer cross-sex hormones or puberty-blocking drugs for the purpose of a gender transition for children. This provision of law does not apply to those children who were prescribed or administered such drugs prior to August 28, 2023. This prohibition on the prescription of cross-sex hormones or puberty-blocking drugs to children shall expire on August 28, 2027. This act removes that expiration date. Additionally, the provision excluding those children already prescribed or administered the hormones or drugs prior to August 28, 2023, from the general prohibition on the prescription of cross-sex hormones or puberty-blocking drugs to children shall expire on March 1, 2027. This act is substantially similar to HCS/HBs 2033, 1608, 1672, & 1854 (2026), SB 1264 (2026), SB 861 (2026), SB 75 (2025), HCS#2/SS#2/SCS/SB 10 (2025), SB 26 (2025), SB 249 (2025), SB 493 (2025), SB 1185 (2024), SB 726 (2024), and SB 776 (2024). SARAH HASKINS
Who sponsors SB 1200?
SB 1200 is sponsored by Brad Hudson.
What is the current status of SB 1200?
This bill is in committee in the Senate. Introduced December 01, 2025. It must pass committee before a floor vote.
Where can I track SB 1200?
Track SB 1200 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SB 1200

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of SB 1200

Last checked for changes about 2 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →